Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 2,639,353 | 1,571,922 | 1,180,534 | 983,518 |
| Cost of revenue | 872,862 | 792,427 | 678,977 | 397,686 |
| Gross profit | 1,766,491 | 779,495 | 501,557 | 585,832 |
| Advertising and marketing | 391,047 | 182,121 | 229,651 | 147,605 |
| Professional fees | 528,155 | 378,487 | 316,393 | 363,533 |
| Officer compensation | 22,500 | 22,500 | 22,500 | 22,500 |
| Depreciation and amortization expense | 97,694 | 98,343 | 76,078 | 54,832 |
| Investor relations | 21,500 | 15,000 | 25,000 | 40,000 |
| General and administrative | 475,812 | 389,319 | 277,696 | 207,448 |
| Total operating expenses | 1,536,708 | 1,085,770 | 947,318 | 835,918 |
| Income from operations | 229,783 | -306,275 | -445,761 | -250,086 |
| Interest expense | 2,190,549 | 2,007,597 | 3,490,962 | 1,055,371 |
| Change in the fair value of derivative liability | 1,084,492 | 921,030 | -865 | -328 |
| Gain on extinguishment of debt | NaN | -2 | -416,155 | NaN |
| Total other expense | -1,106,057 | -1,086,569 | -3,907,980 | -1,055,699 |
| Net loss | -876,274 | -1,392,843 | -4,353,741 | -1,305,785 |
| Basic EPS | -0.07 | -0.108 | -0.35 | -0.1 |
| Diluted EPS | -0.07 | -0.108 | -0.35 | -0.1 |
| Basic Average Shares | 13,138,968 | 12,920,336 | 12,538,968 | 12,538,968 |
| Diluted Average Shares | 13,138,968 | 12,920,336 | 12,538,968 | 12,538,968 |